Stock listing
PTHS Stock Price, News, Filings & Events — Pelthos Therapeutics Inc.
Selected listing: PTHS · BOATS · USD · US
This page tracks Pelthos Therapeutics Inc.'s PTHS:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PTHS:BOATS. PTHS:BOATS is the stock-level entry point for investors researching Pelthos Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pelthos Therapeutics Inc. is a public company traded under the ticker PTHS in the American market. The company has a market capitalization of approximately $90 million. Pelthos focuses on developing innovative therapeutic solutions, contributing to advancements in healthcare.

- Ticker
- PTHS:BOATS
- Asset type
- Stock
- Market cap
- $94.7M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BOATS
- Currency
- USD
Pelthos Therapeutics Inc. PTHS:BOATS stock context
This page tracks Pelthos Therapeutics Inc.'s PTHS:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PTHS:BOATS. PTHS:BOATS is the stock-level entry point for investors researching Pelthos Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Pelthos Therapeutics Inc. is a public company traded under the ticker PTHS in the American market. The company has a market capitalization of approximately $90 million. Pelthos focuses on developing innovative therapeutic solutions, contributing to advancements in healthcare.
Latest news from Pelthos Therapeutics Inc.
Pelthos Therapeutics Announces First Quarter 2026 Financial Results
May 14, 2026
Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026
May 1, 2026
Pelthos Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium
April 14, 2026
Pelthos Therapeutics Announces CFO Transition
April 10, 2026
Pelthos Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of CT2000 in Eye Pain
March 31, 2026
Pelthos Therapeutics Inc. earnings calls
Pelthos Therapeutics Inc. (PTHS) Q2 2026 Earnings Call
August 13, 2026 · Replay with transcript and chapters
Pelthos Therapeutics Inc. (PTHS) Q1 2026 Earnings Call
May 14, 2026 · Replay with transcript and chapters
Pelthos Therapeutics Inc. (PTHS) Q4 2025 Earnings Call
March 19, 2026 · Replay with transcript and chapters
Research Pelthos Therapeutics Inc.
Pelthos Therapeutics Inc. investor report
Review AI stock analysis and investor report context for PTHS:BOATS.
Pelthos Therapeutics Inc. company profile
View the public company page for Pelthos Therapeutics Inc. on 6ix.
Pelthos Therapeutics Inc. news
Read company news and market updates connected to Pelthos Therapeutics Inc..
Pelthos Therapeutics Inc. investor events
Find investor webinars, events, and replay context for Pelthos Therapeutics Inc..